Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine.
Journal
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
14
05
2022
revised:
24
06
2022
accepted:
21
07
2022
pubmed:
8
8
2022
medline:
15
9
2022
entrez:
7
8
2022
Statut:
ppublish
Résumé
Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.
Identifiants
pubmed: 35933829
pii: S1090-3798(22)00118-0
doi: 10.1016/j.ejpn.2022.07.007
pmc: PMC9339169
pii:
doi:
Substances chimiques
Nimodipine
57WA9QZ5WH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
40-43Informations de copyright
© 2022 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All authors have agreed to this final version of the paper being submitted to the journal and that all contributed equally or give details on the differences of contribution and that there are no conflicts or interest or details if there are conflicts of interest.